Literature DB >> 8344982

Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.

H W Schnaper1, D S Grant, W G Stetler-Stevenson, R Fridman, G D'Orazi, A N Murphy, R E Bird, M Hoythya, T R Fuerst, D L French.   

Abstract

It has been proposed that proteases are important in endothelial cell behavior. We examined the contribution of the gelatinase/type IV collagenase system in an in vitro model of endothelial differentiation. Human umbilical vein endothelial cells rapidly align and form networks of tubes when cultured on a basement membrane preparation, Matrigel. Zymograms of culture supernates demonstrate a 72-kD and a 92-kD gelatinase activity; the cells produce most of the 72-kD gelatinase, whereas the 92-kD activity is derived entirely from the Matrigel. Addition of antibodies against type IV gelatinase/collagenase decreases the area of the tube network. Both tissue inhibitors of metalloproteinases, TIMP-1 and TIMP-2, similarly decrease tube formation when added to cultures. Conversely, exogenous recombinant 72-kD gelatinase increases tube-forming activity. The effects of the anti-gelatinase antibodies and the TIMPs are not additive. Inhibition by either antibodies or TIMPs is greatest when they are added at culture initiation, suggesting that the protease activity is important in the early steps of morphogenesis. However, culture of the cells on Matrigel does not increase early expression of mRNA for the 72-kD gelatinase. Expression of message for the enzyme actually decreases during the course of the assay, while transcription of mRNAs for TIMPs increases, further supporting the concept that collagenases facilitate an early event in tube formation. These data demonstrate that gelatinase/type IV collagenase activity is important in endothelial cell morphogenesis on Matrigel, and suggest a role for collagenases in formation of new capillaries in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344982     DOI: 10.1002/jcp.1041560204

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  58 in total

Review 1.  Extracellular matrix degradation by metalloproteinases and central nervous system diseases.

Authors:  A Lukes; S Mun-Bryce; M Lukes; G A Rosenberg
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

2.  Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.

Authors:  L Guedez; A J McMarlin; D W Kingma; T A Bennett; M Stetler-Stevenson; W G Stetler-Stevenson
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 3.  Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention.

Authors:  W G Stetler-Stevenson
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 4.  Three-dimensional mammary primary culture model systems.

Authors:  M M Ip; K M Darcy
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

5.  Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells.

Authors:  Giulia Taraboletti; Sandra D'Ascenzo; Patrizia Borsotti; Raffaella Giavazzi; Antonio Pavan; Vincenza Dolo
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

Review 6.  The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.

Authors:  G Cox; W P Steward; K J O'Byrne
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

Review 7.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

8.  Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactions.

Authors:  N Chandrasekar; S Jasti; W K Alfred-Yung; F Ali-Osman; D H Dinh; W C Olivero; M Gujrati; A P Kyritsis; G L Nicolson; J S Rao; S Mohanam
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 9.  Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.

Authors:  Bruce A Corliss; Mohammad S Azimi; Jennifer M Munson; Shayn M Peirce; Walter L Murfee
Journal:  Microcirculation       Date:  2016-02       Impact factor: 2.628

10.  Enhanced skin wound healing by a sustained release of growth factors contained in platelet-rich plasma.

Authors:  Hee Seok Yang; Jaehoon Shin; Suk Ho Bhang; Jung Youn Shin; Jooyeon Park; Gun Il Im; Chang Sung Kim; Byung Soo Kim
Journal:  Exp Mol Med       Date:  2011-11-30       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.